| Latest Insite Vision News Headlines |
| Date | Time | Source | |
| 09/19/2008 | 4:46PM | PRNUS | PTV Sciences Urges All Stockholders to Vote the GOLD Card at InSite Vision's Annual Meeting Scheduled for Monday, September 22,
Settlement Discussions Between PTV Sciences and InSite Vision End
HOUSTON and AUSTIN, Texas, Sept. 19 /PRNewswire/ -- PTV Sciences, a healthcare venture capital and growth equity firm, announced today that recent settlement efforts have ended between PTV Sciences and InSite Vision Incorporated (AMEX:ISV). Accordingly... More...>> |
| 09/15/2008 | 5:22PM | PRNUS | PROXY Governance, Inc. Joins RiskMetrics and Glass Lewis in Recommending Stockholders Vote PTV Sciences' GOLD Proxy Card
Third Independent Advisory Firm Rejects Entire Current Board of Directors, Including the CEO, Kumar Chandrasekaran
HOUSTON and AUSTIN, Texas, Sept. 15 /PRNewswire/ -- PTV Sciences, a healthcare venture capital and growth equity firm, announced today that independent proxy advisory firm PROXY Governance, Inc. has issued... More...>> |
| 09/11/2008 | 5:35PM | PRNUS | RiskMetrics (ISS), An Independent Proxy Advisory Firm, Recommends Voting the GOLD Card for Four of PTV's Nominees: Anderson, McI
RiskMetrics Further Advises Shareholders to Reject Entire Management Slate of InSite Vision, Including the Chairman and Chief Executive Officer
AUSTIN, Texas and HOUSTON, Sept. 11 /PRNewswire/ -- PTV Sciences ("PTV"), a healthcare venture capital and growth equity firm, is pleased to announce that RiskMetrics Group -(Formerly... More...>> |
| 09/11/2008 | 9:04AM | PRNUS | Proxy Advisory Firm Rejects Entire Management Slate of InSite Vision, Including the Chairman and Chief Executive Officer
Glass Lewis & Co. Recommends that Stockholders Vote the GOLD Card in Favor of PTV Nominee Rick Anderson
AUSTIN and HOUSTON, Texas, Sept. 11 /PRNewswire/ -- PTV Sciences ("PTV"), a healthcare venture capital and growth equity firm, is pleased to announce that Glass Lewis and Co., LLC, a leading proxy advisory and corporate... More...>> |
| 01/13/2006 | 7:00AM | PRNUS | InSite Vision Completes Enrollment in Second Phase 3 AzaSite(TM) Clinical Study
AzaSite Demonstrates Efficacy Against Azithromycin Resistant Bacteria
ALAMEDA, Calif., Jan. 13 /PRNewswire-FirstCall/ -- InSite Vision Incorporated (AMEX:ISV) -- an ophthalmic therapeutics, diagnostics and drug-delivery company -- today announced the completion of enrollment for the second of its two pivotal Phase 3... More...>> |
| 05/27/2004 | 4:00AM | PRNUS | InSite Vision to Webcast 2004 Annual Meeting of Stockholders
InSite Vision to Webcast 2004 Annual Meeting of Stockholders
ALAMEDA, Calif., May 27 /PRNewswire-FirstCall/ -- InSite Vision Incorporated
(AMEX:ISV), an ophthalmic therapeutics, diagnostics and drug- delivery company,
today announced that its annual meeting of stockholders will be broadcast live
over the Internet on... More...>> |
| 05/14/2004 | 4:00AM | PRNUS | InSite Vision Reports First Quarter Financial Results
InSite Vision Reports First Quarter Financial Results
Conference Call to Begin at 11:00 a.m. ET Today
ALAMEDA, Calif., May 14 /PRNewswire-FirstCall/ -- InSite Vision Incorporated
-- an ophthalmic therapeutics, diagnostics and drug-delivery company -- today
reported financial results for the three months ended March... More...>> |
| 05/11/2004 | 1:31PM | PRNUS | InSite Vision to Hold 2004 First Quarter Financial Results Conference Call on May 14
InSite Vision to Hold 2004 First Quarter Financial Results
Conference Call on May 14
ALAMEDA, Calif., May 11 /PRNewswire-FirstCall/ -- InSite Vision Incorporated
-- an ophthalmic therapeutics, diagnostics and drug-delivery company -- today
announced that the Company will release 2004 first quarter financial results
before... More...>> |
| 04/02/2004 | 4:04PM | PRNUS | InSite Vision Provides Announcement Regarding Auditors' Opinion
InSite Vision Provides Announcement Regarding Auditors' Opinion
ALAMEDA, Calif., April 2 /PRNewswire-FirstCall/ -- As required by a recently
adopted rule of the American Stock Exchange, InSite Vision Incorporated today
announcedthat the Company's Annual Report on Form 10-K included an explanatory
paragraph by its independent... More...>> |
| 03/30/2004 | 3:00AM | PRNUS | InSite Vision Reports 2003 Fourth Quarter and Full Year Financial Results
InSite Vision Reports 2003 Fourth Quarter and Full Year Financial Results
ALAMEDA, Calif., March 30 /PRNewswire-FirstCall/ -- InSite Vision Incorporated
-- an ophthalmic therapeutics, diagnostics and drug-delivery company -- today
reported financial results for the three months and year ended December 31,
2003.
InSite... More...>> |
| 03/29/2004 | 3:00AM | PRNUS | InSite Vision Obtains Initial $2 Million of $16.5 Million Private Placement
InSite Vision Obtains Initial $2 Million of $16.5 Million Private Placement
Conference Call and Webcast Scheduled Today at 10:30 a.m. ET
ALAMEDA, Calif., March 29 /PRNewswire-FirstCall/ -- InSite Vision Incorporated
, an ophthalmic therapeutics, diagnostics and drug-delivery company, today
announced that it has obtained... More...>> |
| 12/30/2003 | 3:30PM | PRNUS | InSite Vision Completes ISV-403 Sale to Bausch & Lomb
InSite Vision Completes ISV-403 Sale to Bausch & Lomb
ALAMEDA, Calif., Dec. 30 /PRNewswire-FirstCall/ -- InSite Vision Incorporated ,
an ophthalmic therapeutics, diagnostics and drug- delivery company, today
reported the completion of a previously announced transaction whereby InSite
Vision has sold its drug candidate... More...>> |
| 12/19/2003 | 3:49PM | PRNUS | InSite Vision Reaches Agreement to Sell ISV-403 to Bausch & Lomb
InSite Vision Reaches Agreement to Sell ISV-403 to Bausch & Lomb
ALAMEDA, Calif. and ROCHESTER, N.Y., Dec. 19 /PRNewswire-FirstCall/ -- InSite
Vision Incorporated , an ophthalmic therapeutics, diagnostics and drug-delivery
company, and Bausch & Lomb today announced they have reached an agreement
whereby InSite Vision... More...>> |
| 12/05/2003 | 4:00AM | PRNUS | InSite Vision to Webcast 2003 Annual Meeting of Stockholders
InSite Vision to Webcast 2003 Annual Meeting of Stockholders
ALAMEDA, Calif., Dec. 5 /PRNewswire-FirstCall/ -- InSite Vision Incorporated
-- an ophthalmic therapeutics, diagnostics and drug- delivery company -- today
announced that its annual meeting of stockholders will be broadcast live over
the Internet on December... More...>> |
| 11/19/2003 | 4:10PM | PRNUS | InSite Vision Reports Third Quarter Financial Results
InSite Vision Reports Third Quarter Financial Results
ALAMEDA, Calif., Nov. 19 /PRNewswire-FirstCall/ -- InSite Vision Incorporated
-- an ophthalmic therapeutics, diagnostics and drug- delivery company -- today
reported financial results for the three and nine months ended September 30,
2003.
InSite Vision reported... More...>> |
| 11/13/2003 | 12:02PM | PRNUS | InSite Vision Announces Rescheduling of 2003 Third Quarter Financial Results Conference Call to November 19 And Delay in Filing
InSite Vision Announces Rescheduling of 2003 Third Quarter Financial Results
Conference Call to November 19 And Delay in Filing of Form 10-Q
ALAMEDA, Calif., Nov. 13 /PRNewswire-FirstCall/ -- InSite Vision Incorporated
-- an ophthalmic therapeutics, diagnostics and drug-delivery company -- today
announced that the... More...>> |
| 11/13/2003 | 7:45AM | PRNUS | Reminder - InSite Vision to Hold 2003 Third Quarter Financial Results Conference Call on November 13
Reminder - InSite Vision to Hold 2003 Third Quarter Financial Results Conference
Call on November 13
ALAMEDA, Calif., Nov. 13 /PRNewswire-FirstCall/ -- InSite Vision Incorporated
-- an ophthalmic therapeutics, diagnostics and drug-delivery company -- today
announced that the Company will release 2003 third quarter... More...>> |
| 11/12/2003 | 11:53AM | PRNUS | InSite Vision Obtains Final Tranche of $1 Million Interim Financing
InSite Vision Obtains Final Tranche of $1 Million Interim Financing
ALAMEDA, Calif., Nov. 12 /PRNewswire-FirstCall/ -- InSite Vision Incorporated
-- an ophthalmic therapeutics, diagnostics and drug-delivery company -- today
announced that it has obtained the final $500,000 tranche for a total of $1
million in interim... More...>> |
| 11/10/2003 | 3:30PM | PRNUS | InSite Vision to Hold 2003 Third Quarter Financial Results Conference Call on November 13
InSite Vision to Hold 2003 Third Quarter Financial Results Conference Call on
November 13
ALAMEDA, Calif., Nov. 10 /PRNewswire-FirstCall/ -- InSite Vision Incorporated
-- an ophthalmic therapeutics, diagnostics and drug-delivery company -- today
announced that the Company will release 2003 third quarter financial results
after... More...>> |
| 10/28/2003 | 5:20PM | PRNUS | InSite Vision Announces Search for New Independent Auditor
InSite Vision Announces Search for New Independent Auditor
ALAMEDA, Calif., Oct. 28 /PRNewswire-FirstCall/ -- InSite Vision Incorporated
-- an ophthalmic therapeutics, diagnostics and drug-delivery company - today
announced that Ernst & Young, LLP will resign as the Company's independent
auditor following the completion... More...>> |